Jie Bao
First Affiliated Hospital of Zhengzhou University(CN)
Publications by Year
Research Areas
MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Circular RNAs in diseases, Liver Disease Diagnosis and Treatment, Liver Diseases and Immunity
Most-Cited Works
- → LDHA is a direct target of miR‐30d‐5p and contributes to aggressive progression of gallbladder carcinoma(2018)89 cited
- → MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway(2018)86 cited
- → MiR‐139‐5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma(2018)77 cited
- → LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway(2018)55 cited
- → miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2(2017)52 cited
- → Genome‐wide meta‐analysis identifies susceptibility loci for autoimmune hepatitis type 1(2022)36 cited
- → CBX2 is a functional target of miRNA let‐7a and acts as a tumor promoter in osteosarcoma(2019)31 cited
- → UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370(2020)26 cited
- lncRNA USP2-AS1 promotes colon cancer progression by modulating Hippo/YAP1 signaling.(2020)
- → Integration of Metabolomics, Lipidomics, and Proteomics Reveals the Metabolic Characterization of Nonalcoholic Steatohepatitis(2023)18 cited